Allurion Technologies (ALUR) Income from Continuing Operations (2022 - 2026)
Allurion Technologies posted quarterly Income from Continuing Operations of 6095000.0 for Q1 2026, down 306.06% year-on-year from 2957838.67 in Q1 2025, and down 126.48% on a QoQ basis from 23020000.0 in Q4 2025.
Allurion Technologies (ALUR) has 5 years of Income from Continuing Operations data on file, last reported at 6095000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 306.06% year-over-year to 6095000.0; the trailing twelve-month figure through Mar 2026 stood at 4294000.0 (down 24.5% YoY), and the FY2025 full-year result was 347000.0, up 179.84% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 6095000.0, down from 23020000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 62043000.0 in Q4 2023 and bottomed at 21996000.0 in Q2 2023.
- The 5-year median for Income from Continuing Operations is 5750000.0 (2022), against an average of 115875.0.
- The widest annual swing landed in 2023, when Income from Continuing Operations tumbled 306.96%; it then surged 1102.61% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 25962000.0 in 2022, then jumped by 138.98% to 62043000.0 in 2023, then slumped by 103.7% to 2296000.0 in 2024, then soared by 1102.61% to 23020000.0 in 2025, then slumped by 126.48% to 6095000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 6095000.0 (Q1 2026), 23020000.0 (Q4 2025), and 11884000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | -6.48 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.28 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -22.34 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | -13.01 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |